Home Shanghai MicroPort's Bioresorbable Rapamycin-Eluting Coronary Stent System Approved as 282nd Innovative Medical Device in China

Shanghai MicroPort's Bioresorbable Rapamycin-Eluting Coronary Stent System Approved as 282nd Innovative Medical Device in China

Jul 30, 2024 17:30 CST Updated 17:30
MicroPort

High-end Medical Device R&D and Manufacturer